BMJ Open (Sep 2022)

Perspectives of attenders and non-attenders to SARS-CoV-2 asymptomatic community testing in England: a qualitative interview study

  • Shirley Devine,
  • Nicola Richmond,
  • Kaushik Chattopadhyay,
  • Ilze Bogdanovica,
  • Emily Johnston,
  • Tessa Langley,
  • Leah Jayes

DOI
https://doi.org/10.1136/bmjopen-2022-064542
Journal volume & issue
Vol. 12, no. 9

Abstract

Read online

Objectives In December 2020, Derbyshire County Council in England introduced ‘walk-in’ asymptomatic community COVID-19 testing sites. Our study aimed to explore people’s views of the newly established COVID-19 community testing (CT) sites among those who attended and those who did not attend them, alongside gathering individuals’ experiences of attending a CT site to complete a lateral flow test.Setting This qualitative research study comprised of one-to-one interviews with those attending a COVID-19 CT sites in Derbyshire and those from the surrounding area who did not attend.Participants A combination of purposive and convenience sampling was used to recruit those who had (n=18) and those who had not attended (n=15) a walk-in asymptomatic CT site.Results Employers played a key role in raising awareness of the testing sites, with most attending CT at the request of their workplace. The experience of attending a CT site was overwhelmingly positive and those who got tested spoke about the reassurance a negative result offered, knowing they were not passing on the virus when going about their daily lives. However, there was a perception that awareness of CT sites was low across the county and some confusion about who was eligible to attend and under what circumstances. Individuals linked this to low level of advertising they had seen, in addition to a lack of clarity in the information provided.Conclusions People’s experience of attending a ‘walk-in’ asymptomatic CT site in Derbyshire was generally very positive; however, ensuring clear communication for future testing programmes is essential to maximise their uptake.